Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease

Archives of Neurology

Volumn 59, Issue 1, 2002, Pages 71-75

  Padovani, Alessandro ^a   Borroni, Barbara ^a   Colciaghi, Francesca ^b   Pettenati, Carla ^c   Cottini, Elisabetta ^a   Agosti, Chiara ^a   Lenzi, Gian Luigi ^d   Caltagirone, Carlo ^e   Trabucchi, Marco ^f   Cattabeni, Flaminio ^b   Di Luca, Monica ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Alzheimer Centre   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; WESTERN BLOTTING;

EID: 0036144386     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.1.71     Document Type: Article

References (58)

1. Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases
2. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
3. Evidence that age-associated memory impairment is not a normal variant of aging
4. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
5. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
6. Cognitive process in preclinical phase of dementia
7. Predicting conversion to Alzheimer disease using standardized clinical information
8. Aging, mild cognitive impairment and Alzheimer's disease
9. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
10. Mild cognitive impairment in the elderly: Predictors of dementia
11. Mild cognitive impairment: Clinical characterization and outcome
12. Mild cognitive impairment: Conceptual basis and current nosological status
13. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss
14. Mild cognitive impairment represents early-stage Alzheimer disease
15. Classification criteria for mild cognitive impairment: A population-based validation study
16. Of MCI and dementia: Improving diagnosis and treatment
17. "Prodromal Alzheimer's disease": A more useful concept than mild cognitive impairment?
18. Reduction of β-amyloid peptide 1-42 in the cerebrospinal fluid of patients with Alzheimer disease
19. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF
20. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease
21. Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
22. The amyloid precursor protein of Alzheimer's disease is released by human platelets
23. Activated Alzheimer disease platelets retain more beta amyloid precursor protein
24. Secretion of Alzhelmer disease Aβ amyloid peptide by activation of human platelets
25. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome
26. Altered amyloid protein processing in platelets of patients with Alzheimer disease
27. Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelets: The brain delegates in the periphery
28. Differential pattern of platelet APP isoforms: An early marker for Alzheimer disease
29. Platelet APP isoform ratios correlate with declining cognition in AD
30. New biochemical markers in Alzheimer disease
31. Reliability of the Washington University of Clinical dementia rating
32. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
33. A new rating scale for Alzheimer's disease
34. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
35. Geriatric Depression Scale (GDS): Recentevidence and development of a shorter version
36. The Hamilton Anxiety Scale: Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders
37. Assessment of older people: Self-maintaining and instrumental activities of daily living
38. Repeatability and validity of a modified Activities of Daily Living (ADL) Index in studies of chronic disability
39. Raven's Progressive Matrices: Construct validity
40. The Set test as an aid to the detection of dementia in old people
41. Screening for Alzheimer's disease by clock drawing
42. Psychometric construction of the Rey-Osterrieth Complex Figure
43. Validity of the Trail Making Test as an indicator of organic brain damage
44. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease
45. Platelet amyloid precursor protein forms in AD: A peripheral diagnostic tool and a pharmacological target
46. Amyloid precursor protein in platelets of patients with Alzheimer disease: Effect of acetylcholinesterase inhibitor treatment
47. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues
48. Platelets as a peripheral district where to study pathogenetic mechanism of Alzheimer disease: The case of amyloid precursor protein
49. Platelet activation in Alzheimer disease
50. Platelet membrane fluidity
51. Changes in platelet phospholipase C protein level and activity in Alzheimer's disease
52. Platelet protein kinase C levels in Alzheimer's disease
53. Cerebrospinal protein tau is elevated in early Alzheimer's disease
54. Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment, Neurosci Lett
55. Progression to dementia in patients with isolated memory loss